Given the pronounced reduction in AKT levels observed in SKmel147 and the patient-derived melanoma cell lines M161022 and M160915 upon PP treatment, we proceeded to evaluate the effect of PP on key downstream targets of AKT following a 3-day treatment period. The gene discussed is AKT1; the disease is melanoma.